BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32734507)

  • 1. AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway.
    Gu D; Shi Y; Gong Z; Xia T; Ren H; He D; Yang J; Han Y; Zeng C
    Clin Exp Nephrol; 2020 Nov; 24(11):989-998. PubMed ID: 32734507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
    Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
    Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
    Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway.
    Yu J; Zheng J; Lu J; Sun Z; Wang Z; Zhang J
    Neurochem Res; 2019 Jul; 44(7):1678-1689. PubMed ID: 30982205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
    Liu B; Liu J; Wang JG; Liu CL; Yan HJ
    Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
    Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats.
    Zhao Q; Yin J; Lu Z; Kong Y; Zhang G; Zhao B; Wang F
    Cell Physiol Biochem; 2016; 40(3-4):621-632. PubMed ID: 27898408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate‑activated protein kinase signaling pathway.
    Wang SJ; Lu WY; Liu KY
    Mol Med Rep; 2017 Nov; 16(5):7163-7169. PubMed ID: 28901521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AdipoRon Attenuates Neuroinflammation After Intracerebral Hemorrhage Through AdipoR1-AMPK Pathway.
    Zheng J; Sun Z; Liang F; Xu W; Lu J; Shi L; Shao A; Yu J; Zhang J
    Neuroscience; 2019 Aug; 412():116-130. PubMed ID: 31176703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
    Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
    Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation.
    Fang D; Wang Y; Zhang Z; Yang D; Gu D; He B; Zhang X; He D; Wang H; Jose PA; Han Y; Zeng C
    Oxid Med Cell Longev; 2021; 2021():2999296. PubMed ID: 34712381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
    Ramzan AA; Bitler BG; Hicks D; Barner K; Qamar L; Behbakht K; Powell T; Jansson T; Wilson H
    Mol Cell Biochem; 2019 Nov; 461(1-2):37-46. PubMed ID: 31292831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin receptor agonist AdipoRon attenuates calcification of osteoarthritis chondrocytes by promoting autophagy.
    Duan ZX; Tu C; Liu Q; Li SQ; Li YH; Xie P; Li ZH
    J Cell Biochem; 2020 Jun; 121(5-6):3333-3344. PubMed ID: 31898335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
    Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
    J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats.
    Zhao B; Zhao Q; Li J; Xing T; Wang F; Wang N
    PLoS One; 2015; 10(1):e0116583. PubMed ID: 25635854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
    Wang Y; Liang B; Lau WB; Du Y; Guo R; Yan Z; Gan L; Yan W; Zhao J; Gao E; Koch W; Ma XL
    Autophagy; 2017; 13(11):1855-1869. PubMed ID: 28825851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AdipoRon Attenuates Hypertension-Induced Epithelial-Mesenchymal Transition and Renal Fibrosis via Promoting Epithelial Autophagy.
    Li Y; Song B; Ruan C; Xue W; Zhao J
    J Cardiovasc Transl Res; 2021 Jun; 14(3):538-545. PubMed ID: 33025271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways.
    Gao Z; Han Y; Hu Y; Wu X; Wang Y; Zhang X; Fu J; Zou X; Zhang J; Chen X; Jose PA; Lu X; Zeng C
    PLoS One; 2016; 11(2):e0149032. PubMed ID: 26866373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.